Zobrazeno 1 - 1
of 1
pro vyhledávání: '"RELAJANTES MUSCULARES CENTRALES - ADMINISTRACIÓN Y DOSIFICACIÓN"'
Autor:
Morales Escobar, Viviana
Publikováno v:
Murphy GS, Szokol J. Intraoperative Acceleromyography monitoring reduces symptoms of muscle
Murphy G, Brull SJ. Residual neuromuscular block: Lesson unlearned. Part I: Definitions
Sauer M, Stahn A. The influence of residual neuromuscualr block on the incidence of critical
Gold SJA, Harper NJN. The place of sugammadex in anaesthesia practive. Trends in Anaesthesia
Akha AS, Rosa III J. Sugammadex: Cyclodextrins, development of selective binding agent
Kam P, Kuijk Jv. Effects of sugammadex doses up to 32mg/kg alone or in combination with
Abrishami A, Joyce H, Jean W. Sugammadex, a selective reversal medication for preventing
Miller RD. Neuromuscular Blocking Drugs. In Miller RD, Pardo MC. Basics of Anesthesia.
Kovac AL. Sugammadex: the fist selective binding reversal agent for neuromuscular block. journal
Sugammadex NDA 22-225 Anesthetic an life support drugs advisory commitee, Organon a part of
Calvey TN. Drugs that act on the Neuromuscular Juction. In Calvey TN. Principles an pactice of
Naguib M, Lien CA. Pharmacology of Muscle Relaxant and Their Antagonists. In Miller RD, al. e.
Viby-Mogensen J. Neuromuscular Monitoring. In Miller RD, editor. Miller's Anesthesia. San
Brull SJ, Murphy GS. Residual Neuromuscular Block: Lessons Unlearned. Part II: Methods to
Caldwell JE. Reversal of Residual Neuromuscular Block with neostigmine at One to Four hous after
Ploeger BA, Smeets J. Pharmacokinetric-Pharmacodynamic Model for the Reversal of
Jadad AR, Moore RA. Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding
Pühringer FK, Gordon M. Sugammadex rapidly reverses moderate rocuronium or vecuronium
Lemmens H, El-Orbany MI. Reversal of profound vecuronium induced neuromuscular block under
Khuenl-Brady K, Wattwil M. Sugammadex provides faster reversal of vecuronium induced
Suy K, Morias K. Effective reversal of moderate rocuronium or vecuronium-induced
Geldner G, Niskenen M. A randomised control trial comparing sugammadex and neostigmine at
Duvaldestin P, Kuizenga K. A randomized, Dose-response study of sugammadex given for reversal
Abrishami A, Ho J. Sugammadex, a selective reversal medication for preventing postoperative
Sugammadex USFIalf. Sugammadex. [Online].; 2008 [cited 2013 feb 18 [rechazo de la FDA para
Bom A. Preclinical pharmacology of sugammadex. Journal of critical care. 2009; 24: p. 29-35.
injection MaFaorondafss. Sugammadex. [Online].; 2013 [cited 2013 febrero 18 [autorizacion de
McDonnell, N.J.. Case report: sugammadex in the management of rocuronium induced
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Murphy G, Brull SJ. Residual neuromuscular block: Lesson unlearned. Part I: Definitions
Sauer M, Stahn A. The influence of residual neuromuscualr block on the incidence of critical
Gold SJA, Harper NJN. The place of sugammadex in anaesthesia practive. Trends in Anaesthesia
Akha AS, Rosa III J. Sugammadex: Cyclodextrins, development of selective binding agent
Kam P, Kuijk Jv. Effects of sugammadex doses up to 32mg/kg alone or in combination with
Abrishami A, Joyce H, Jean W. Sugammadex, a selective reversal medication for preventing
Miller RD. Neuromuscular Blocking Drugs. In Miller RD, Pardo MC. Basics of Anesthesia.
Kovac AL. Sugammadex: the fist selective binding reversal agent for neuromuscular block. journal
Sugammadex NDA 22-225 Anesthetic an life support drugs advisory commitee, Organon a part of
Calvey TN. Drugs that act on the Neuromuscular Juction. In Calvey TN. Principles an pactice of
Naguib M, Lien CA. Pharmacology of Muscle Relaxant and Their Antagonists. In Miller RD, al. e.
Viby-Mogensen J. Neuromuscular Monitoring. In Miller RD, editor. Miller's Anesthesia. San
Brull SJ, Murphy GS. Residual Neuromuscular Block: Lessons Unlearned. Part II: Methods to
Caldwell JE. Reversal of Residual Neuromuscular Block with neostigmine at One to Four hous after
Ploeger BA, Smeets J. Pharmacokinetric-Pharmacodynamic Model for the Reversal of
Jadad AR, Moore RA. Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding
Pühringer FK, Gordon M. Sugammadex rapidly reverses moderate rocuronium or vecuronium
Lemmens H, El-Orbany MI. Reversal of profound vecuronium induced neuromuscular block under
Khuenl-Brady K, Wattwil M. Sugammadex provides faster reversal of vecuronium induced
Suy K, Morias K. Effective reversal of moderate rocuronium or vecuronium-induced
Geldner G, Niskenen M. A randomised control trial comparing sugammadex and neostigmine at
Duvaldestin P, Kuizenga K. A randomized, Dose-response study of sugammadex given for reversal
Abrishami A, Ho J. Sugammadex, a selective reversal medication for preventing postoperative
Sugammadex USFIalf. Sugammadex. [Online].; 2008 [cited 2013 feb 18 [rechazo de la FDA para
Bom A. Preclinical pharmacology of sugammadex. Journal of critical care. 2009; 24: p. 29-35.
injection MaFaorondafss. Sugammadex. [Online].; 2013 [cited 2013 febrero 18 [autorizacion de
McDonnell, N.J.. Case report: sugammadex in the management of rocuronium induced
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: En 1979, con la monitorización del uso rutinario de los relajantes neuromusculares, se determinó incidencia en la relajación neuromuscular residual del 45%, con múltiples complicaciones respiratorias que incrementan la estancia hos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28da22dfe2415d64df7af5c26bb06834
